Somewhat Positive Media Coverage Somewhat Unlikely to Impact Mesoblast Limited (MESO) Share Price

Media stories about Mesoblast Limited (NASDAQ:MESO) have trended somewhat positive on Tuesday, Accern Sentiment reports. The research group scores the sentiment of press coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Mesoblast Limited earned a coverage optimism score of 0.19 on Accern’s scale. Accern also assigned news headlines about the company an impact score of 46.8576170387686 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.

These are some of the news headlines that may have effected Accern Sentiment’s scoring:

A number of equities research analysts have recently weighed in on MESO shares. Zacks Investment Research downgraded Mesoblast Limited from a “buy” rating to a “sell” rating in a research note on Wednesday, May 17th. Maxim Group set a $14.00 price target on Mesoblast Limited and gave the stock a “buy” rating in a research note on Thursday, May 25th. Cantor Fitzgerald started coverage on Mesoblast Limited in a research note on Wednesday, June 7th. They set a “buy” rating and a $20.00 price target for the company. BidaskClub downgraded Mesoblast Limited from a “hold” rating to a “sell” rating in a research note on Wednesday, July 12th. Finally, Credit Suisse Group set a $11.00 price target on Mesoblast Limited and gave the stock a “hold” rating in a research note on Tuesday, July 18th. One research analyst has rated the stock with a sell rating, three have given a hold rating and four have assigned a buy rating to the company’s stock. Mesoblast Limited currently has a consensus rating of “Hold” and an average price target of $13.64.

Shares of Mesoblast Limited (NASDAQ:MESO) traded down 3.24% on Tuesday, hitting $5.67. The company had a trading volume of 17,947 shares. Mesoblast Limited has a 12-month low of $4.01 and a 12-month high of $12.50. The firm’s market capitalization is $481.29 million. The firm has a 50 day moving average of $6.76 and a 200-day moving average of $8.29.

TRADEMARK VIOLATION NOTICE: This article was first published by Stock Observer and is the property of of Stock Observer. If you are accessing this article on another publication, it was illegally stolen and republished in violation of US and international trademark and copyright legislation. The original version of this article can be viewed at https://www.thestockobserver.com/2017/09/12/somewhat-positive-media-coverage-somewhat-unlikely-to-impact-mesoblast-limited-meso-share-price.html.

Mesoblast Limited Company Profile

Insider Buying and Selling by Quarter for Mesoblast Limited (NASDAQ:MESO)

Receive News & Ratings for Mesoblast Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesoblast Limited and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply